Literature DB >> 26123181

Screening Tests for Osteoporosis: Too Few for Some, Too Many for Others.

Douglas C Bauer1.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 26123181      PMCID: PMC4636572          DOI: 10.1007/s11606-015-3446-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  9 in total

1.  The value of routine BMD monitoring after starting bisphosphonate treatment.

Authors:  Katy J L Bell; Andrew Hayen; Les Irwig; Petra Macaskill; Jonathan C Craig; Kristine E Ensrud; Douglas C Bauer
Journal:  J Bone Miner Res       Date:  2010-01       Impact factor: 6.741

2.  Cost-effectiveness of oral bisphosphonates for osteoporosis at different ages and levels of life expectancy.

Authors:  Annalise N Pham; Santanu K Datta; Thomas J Weber; Louise C Walter; Cathleen S Colón-Emeric
Journal:  J Am Geriatr Soc       Date:  2011-08-30       Impact factor: 5.562

3.  Underuse and Overuse of Osteoporosis Screening in a Regional Health System: a Retrospective Cohort Study.

Authors:  Anna Lee D Amarnath; Peter Franks; John A Robbins; Guibo Xing; Joshua J Fenton
Journal:  J Gen Intern Med       Date:  2015-05-19       Impact factor: 5.128

4.  Screening for osteoporosis: U.S. preventive services task force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2011-01-17       Impact factor: 25.391

5.  Bone-density testing interval and transition to osteoporosis in older women.

Authors:  Margaret L Gourlay; Jason P Fine; John S Preisser; Ryan C May; Chenxi Li; Li-Yung Lui; David F Ransohoff; Jane A Cauley; Kristine E Ensrud
Journal:  N Engl J Med       Date:  2012-01-19       Impact factor: 91.245

6.  Longitudinal trends in use of bone mass measurement among older americans, 1999-2005.

Authors:  Jeffrey R Curtis; Laura Carbone; Hong Cheng; Burton Hayes; Andrew Laster; Robert Matthews; Kenneth G Saag; Robert Sepanski; Simpson B Tanner; Elizabeth Delzell
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

7.  Continuing bisphosphonate treatment for osteoporosis--for whom and for how long?

Authors:  Dennis M Black; Douglas C Bauer; Ann V Schwartz; Steven R Cummings; Clifford J Rosen
Journal:  N Engl J Med       Date:  2012-05-09       Impact factor: 91.245

8.  The osteoporosis treatment gap.

Authors:  John A Kanis; Axel Svedbom; Nicholas Harvey; Eugene V McCloskey
Journal:  J Bone Miner Res       Date:  2014-09       Impact factor: 6.741

9.  Clinician's Guide to Prevention and Treatment of Osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2014-08-15       Impact factor: 4.507

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.